Prevalence and Impact of Frailty on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair in the United States

Abstract Background Frailty commonly coexists with severe tricuspid regurgitation, but its impact on outcomes following tricuspid transcatheter edge-to-edge repair (T-TEER) remains unclear. Aims To assess the prevalence of frailty among patients undergoing T-TEER and its association with in-hospital outcomes and short-term readmissions in the United States. Methods A retrospective cohort study was conducted using the Nationwide Readmissions Database (2016–2022) to identify hospitalizations for T-TEER among adults. Frailty was defined using ≥1 Johns Hopkins Adjusted Clinical Groups diagnostic cluster. The primary outcome was major adverse events (MAEs), a composite of in-hospital mortality, major bleeding, vascular complications, pericardial effusion requiring intervention, or conversion to surgery. Secondary outcomes included individual components of the primary outcome, length of stay (LOS), costs, discharge disposition, and 90-day readmissions. Propensity score matching (PSM) was performed to adjust for potential confounders. Results Among 3,046 weighted T-TEER hospitalizations, 171 (5.6%) were classified as frail. After PSM, frailty was associated with higher rates of MAE (29.8% vs 16.9%; odds ratio 2.09, 95% CI 1.03–4.26; p=0.04), major bleeding, and acute kidney injury, longer LOS (12 vs 6 days; p<0.001), higher costs ($86,308 vs $68,690; p<0.001), and numerically higher nonhome discharges (21.1% vs 11.3%; p=0.10). Other in-hospital complications and 90-day all-cause readmissions (hazard ratio 1.24; 95% CI 0.63–2.47; p=0.53) were not significantly different between frail and non-frail groups. Conclusions Frailty is associated with worse in-hospital outcomes after T-TEER but no statistically significant difference in 90-day readmissions was detected. Incorporating frailty assessment may aid prognostication and risk stratification to optimize patient selection for T-TEER.

Authors

Institutions

Publication Details

Journal
European Heart Journal - Valvular and Structural Heart Disease
Published
2026-08-28
DOI
https://doi.org/10.1093/ehjvshd/xwag077
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prevalence and Impact of Frailty on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair in the United States

Mahmoud Ismayl, Mayra Guerrero, Mackram F Eleid, Andrew M Goldsweig et al.
European Heart Journal - Valvular and Structural Heart Disease
Cardiac Valve Diseases and Treatments
article

Prevalence and Impact of Frailty on Outcomes After Tricuspid Transcatheter Edge-to-Edge Repair in the United States

Mahmoud Ismayl, Mayra Guerrero, Mackram F Eleid, Andrew M Goldsweig, Charanjit S Rihal
article en

Abstract

Abstract Background Frailty commonly coexists with severe tricuspid regurgitation, but its impact on outcomes following tricuspid transcatheter edge-to-edge repair (T-TEER) remains unclear. Aims To assess the prevalence of frailty among patients undergoing T-TEER and its association with in-hospital outcomes and short-term readmissions in the United States. Methods A retrospective cohort study was conducted using the Nationwide Readmissions Database (2016–2022) to identify hospitalizations for T-TEER among adults. Frailty was defined using ≥1 Johns Hopkins Adjusted Clinical Groups diagnostic cluster. The primary outcome was major adverse events (MAEs), a composite of in-hospital mortality, major bleeding, vascular complications, pericardial effusion requiring intervention, or conversion to surgery. Secondary outcomes included individual components of the primary outcome, length of stay (LOS), costs, discharge disposition, and 90-day readmissions. Propensity score matching (PSM) was performed to adjust for potential confounders. Results Among 3,046 weighted T-TEER hospitalizations, 171 (5.6%) were classified as frail. After PSM, frailty was associated with higher rates of MAE (29.8% vs 16.9%; odds ratio 2.09, 95% CI 1.03–4.26; p=0.04), major bleeding, and acute kidney injury, longer LOS (12 vs 6 days; p<0.001), higher costs ($86,308 vs $68,690; p<0.001), and numerically higher nonhome discharges (21.1% vs 11.3%; p=0.10). Other in-hospital complications and 90-day all-cause readmissions (hazard ratio 1.24; 95% CI 0.63–2.47; p=0.53) were not significantly different between frail and non-frail groups. Conclusions Frailty is associated with worse in-hospital outcomes after T-TEER but no statistically significant difference in 90-day readmissions was detected. Incorporating frailty assessment may aid prognostication and risk stratification to optimize patient selection for T-TEER.

European Heart Journal - Valvular and Structural Heart Disease
Baystate Medical Center (US), Baystate Health (US), Mayo Clinic in Arizona (US)
Good health and well-being
Openalex Percentile: Top 10%
Cardiac Valve Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.